Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL265958 | 1.00 | MEN1 (0.36) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL29390301 | 1.00 | MEN1 (0.36) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL12449150 | 1.00 | MEN1 (0.36) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL14553368 | 0.80 | MEN1 (0.37) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL1643317 | 0.76 | — | — | |
| SCHEMBL762450 | 0.76 | — | — | |
| SCHEMBL24420094 | 0.75 | HTT (0.33) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL4405125 | 0.73 | — | — | |
| SCHEMBL7662496 | 0.72 | SMN1; SMN2 (0.34) | MEN1KMT2A | |
| SCHEMBL13498357 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024028255-A1 | POLY(AMINO ACID) BASED CAPSULES | AGFA-GEVAERT NV (BE) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023003515-A2 | FUNCTIONALISED POLYPEPTIDES, NANOPARTICLES AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-01-26 | — | — | WO | disclosed |
| WO-2022194759-A1 | POLY(AMINO ACID) BASED CAPSULES | AGFA-GEVAERT NV (BE) | 2022-09-22 | — | — | WO | disclosed |
| EP-4019493-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | FUJIFILM Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-05 | — | — | US | disclosed |
| CN-111643674-B | Polyamino acid carrier with middle acid-sensitive connecting arm and preparation method and application thereof | 中国药科大学 | 2022-03-25 | — | — | CN | disclosed |
| EP-3572408-B1 | METHOD FOR PURIFYING AN AMINO ACID-N-CARBOXY ANHYDRIDE | SHINETSU CHEMICAL CO (JP) | 2021-10-27 | — | — | EP | disclosed |
| CN-111534494-B | (R) -omega-transaminase mutant and application thereof in preparation of sitagliptin intermediate | 浙江工业大学 | 2021-10-01 | — | — | CN | disclosed |
| CN-111411094-B | (R) -omega-transaminase mutant and application thereof | 浙江工业大学 | 2021-10-01 | — | — | CN | disclosed |
| CN-110951706-A | Recombinant R-omega-transaminase, mutant and application in asymmetric synthesis of sitagliptin | 浙江工业大学 | 2020-04-03 | — | — | CN | disclosed |
| CN-110904066-A | Recombinant R-type transaminase, mutant and application thereof | 浙江工业大学 | 2020-03-24 | — | — | CN | disclosed |
| US-8841440-B2 | Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof | CORNELL UNIVERSITY (US) | 2014-09-23 | — | — | US | disclosed |
| US-8841440-B2 | Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof | CORNELL UNIVERSITY (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130143821-A1 | HYDROPHOBICALLY-MODIFIED HYALURONAN AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-06-06 | — | — | US | disclosed |
| US-20110150999-A1 | Organo-Soluble Chitosan Salts and Chitosan-Derived Biomaterials Prepared Thereof | CORNELL UNIVERSITY | 2011-06-23 | — | — | US | disclosed |
| US-20110150999-A1 | Organo-Soluble Chitosan Salts and Chitosan-Derived Biomaterials Prepared Thereof | CORNELL UNIVERSITY | 2011-06-23 | — | — | US | disclosed |
| US-5750735-A | CHEMICAL INTERMEDIATES FOR ANTIBIOTICS | AMERICAN CYANAMID COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744465-A | Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5623081-A | USING BENZYLOXYACETALDEHYDE DIMETHYL ETHER, HALOGENATED 1-PHENYLMETHOXY-4-PENTEN-2-OL; CYCLIZATION | LIN YANG-I (US) | 1997-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | PARG, PTGIS, MT-ATP8 | MEN1 3206/4885KMT2A 3614/4885GAA 3126/4885 |
| US-20130143821-A1 | HYDROPHOBICALLY-MODIFIED HYALURONAN AND METHODS OF MAKING AND USING THEREOF | CD44, HPSE, HACD3 | MEN1 1281/4885KMT2A 3730/4885GAA 682/4885 |
| US-20110150999-A1 | Organo-Soluble Chitosan Salts and Chitosan-Derived Biomaterials Prepared Thereof | CHIA, CHI3L2, CHI3L1 | MEN1 1357/4885KMT2A 4282/4885GAA 1360/4885 |
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | NOXO1, MT-CO2, MT-ATP8 | MEN1 3530/4885KMT2A 2633/4885GAA 2284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.